| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |